Total Funding
1
Total FundingSeries D raised
Growth Score
pts
Heat Score
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
646725
Aragon Pharmaceuticals develops therapeutics for the treatment of hormone-resistant cancers such as prostate and breast cancer.
- Paul Cleveland: Executive Vice President of Corporate Strategy Chief Financial OfficerPast Role: Celladon, President and Chief Executive Officer
About the Company
Aragon Pharmaceuticals is a discovery-stage small molecule company focused on therapeutics for the treatment of hormone-resistant cancers, with an initial focus on prostate and breast cancer.
